Pediatric Intensive Care Unit, Mansoura University Children Hospital, PO Box 63, Mansoura, Egypt.
Eur J Pediatr. 2012 Feb;171(2):383-8. doi: 10.1007/s00431-011-1559-6. Epub 2011 Sep 10.
To demonstrate safety and efficacy of using normal saline (NS) for initial volume expansion (IVE) and rehydration in children with diarrhea-related hypernatremic dehydration (DR-HD), forty eight patients with DR-HD were retrospectively studied. NS was used as needed for IVE and for initial rehydration. Fluid deficit was given over 48 h. Median Na(+) level on admission was 162.9 mEq/L (IQR 160.8-165.8). The median average hourly drop at 6 and 24 h was 0.53 mEq/L/h (0.48-0.59) and 0.52 mEq/L/h (0.47-0.57), respectively. Compared to children not needing IVE, receiving ≥40 ml/kg IVE was associated with a higher average hourly drop of Na(+) at 6 h (0.51 vs. 0.58 mEq/L/h, p = 0.013) but not at 24 h (p = 0.663). The three patients (6.3%) with seizures had a higher average hourly drop of Na(+) at 6 and 24 h (p = 0.084 and 0.021, respectively). Mortality (4/48, 8.3%) was not related to Na(+) on admission or to its average hourly drop at 6 or 24 h. Children receiving ≥40 ml/kg IVE were more likely to die (OR 3.3; CI, 1.5-7.2).
In children with DR-HD, NS is a safe rehydration fluid with a satisfactory rate of Na(+) drop and relatively low incidence of morbidity and mortality. Judicious use of IVE should be exerted and closer monitoring should be guaranteed for children requiring large volumes for IVE and for those showing rapid initial drop of serum Na(+) to avoid neurological complications and poor outcome.
证明在腹泻相关高渗性脱水(DR-HD)患儿中使用生理盐水(NS)进行初始容量扩张(IVE)和补液的安全性和疗效,对 48 例 DR-HD 患儿进行回顾性研究。根据需要使用 NS 进行 IVE 和初始补液。液体不足在 48 小时内给予。入院时中位 Na+水平为 162.9 mEq/L(IQR 160.8-165.8)。6 小时和 24 小时的中位平均每小时下降值分别为 0.53 mEq/L/h(0.48-0.59)和 0.52 mEq/L/h(0.47-0.57)。与不需要 IVE 的患儿相比,接受≥40 ml/kg IVE 的患儿在 6 小时时 Na+的平均每小时下降幅度更高(0.51 与 0.58 mEq/L/h,p=0.013),但在 24 小时时无差异(p=0.663)。3 例(6.3%)抽搐患儿在 6 小时和 24 小时时 Na+的平均每小时下降幅度更高(p=0.084 和 0.021)。死亡率(4/48,8.3%)与入院时的 Na+或 6 小时和 24 小时时的平均每小时下降值无关。接受≥40 ml/kg IVE 的患儿更有可能死亡(OR 3.3;CI,1.5-7.2)。
在 DR-HD 患儿中,NS 是一种安全的补液液,具有令人满意的 Na+下降率和相对较低的发病率和死亡率。应谨慎使用 IVE,并应保证对需要大量 IVE 的患儿和血清 Na+初始快速下降的患儿进行密切监测,以避免神经系统并发症和不良预后。